Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
The International Journal of Cardiovascular Imaging

Open Access 05-11-2024 | Transthoracic Echocardiography | Review

Disparities in quantification of mitral valve regurgitation between cardiovascular magnetic resonance imaging and trans-thoracic echocardiography: a systematic review

Authors: Sulayman el Mathari, Rahul A. Bhoera, Luuk H. G. A. Hopman, Josephine Heidendael, Arjan Malekzadeh, Aart Nederveen, Pim van Ooij, Marco J. W. Götte, Jolanda Kluin

Published in: The International Journal of Cardiovascular Imaging

Login to get access

Abstract

Primary mitral regurgitation (MR) is a prevalent valvular heart disease. Therapy stratification for MR depends on accurate assessment of MR severity and left ventricular (LV) dimensions. While trans-thoracic echocardiography (TTE) has been the standard/preferred assessment method, cardiovascular magnetic resonance imaging (CMR) has gained recognition for its superior assessment of LV dimensions and MR severity. Both imaging modalities have their own advantages and limitation for therapy guidance. However, the differences between the two modalities for assessing/grade severity and clinical impact of MR remains unclear. This systematic review aims to evaluate the differences between TTE and CMR in quantifying MR severity and LV dimensions, providing insights for optimal clinical management. A literature search was performed from inception up to March 21st 2023. This resulted in 2,728 articles. After screening, 22 articles were deemed eligible for inclusion in the meta-analysis. The included study variables were, mitral valve regurgitation volume (MRVOL), regurgitation fraction (MRFRAC), LV end-diastolic volume (LVEDV), LV end-systolic volume (LVESV), LV stroke volume (LVSV), and LV ejection fraction (LVEF). TTE showed a significant higher MRVOL (10.4 ml, I2 = 88%, p = 0.002) and MRFRAC (6.3%, I2 = 51%, p = 0.05) compared to CMR, while CMR demonstrated a higher LVEDV (21.9 ml, I2 = 66%, p =  < 0.001) and LVESV (16.8 ml, I2 = 0%, p =  < 0.001) compared to TTE. Our findings demonstrate substantial disparities in TTE and CMR derived measurements for parameters that play a pivotal role in the clinical stratification guidelines. This discrepancy prompts a critical question regarding the prognostic value of both imaging modalities, which warrants future research.

Graphical abstract

Appendix
Available only for authorised users
Literature
1.
2.
Iung B, Delgado V, Rosenhek R, Price S, Prendergast B, Wendler O et al (2019) Contemporary presentation and management of valvular heart disease: the EURObservational research programme valvular heart disease II survey. Circulation 140(14):1156–1169PubMedCrossRef
3.
Antoine C, Benfari G, Michelena HI, Maalouf JF, Nkomo VT, Thapa P, Enriquez-Sarano M (2018) Clinical outcome of degenerative mitral regurgitation: critical importance of echocardiographic quantitative assessment in routine practice. Circulation 138(13):1317–1326PubMedCrossRef
4.
Douedi S, Douedi H (2023) Mitral regurgitation. StatPearls, Treasure Island
5.
Dziadzko V, Clavel MA, Dziadzko M, Medina-Inojosa JR, Michelena H, Maalouf J et al (2018) Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet 391(10124):960–969PubMedPubMedCentralCrossRef
6.
El Sabbagh A, Reddy YNV, Nishimura RA (2018) Mitral valve regurgitation in the contemporary era: insights into diagnosis, management, and future directions. JACC Cardiovasc Imaging 11(4):628–643PubMedCrossRef
7.
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J et al (2022) 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol (Engl Ed) 75(6):524PubMed
8.
Wu S, Chai A, Arimie S, Mehra A, Clavijo L, Matthews RV, Shavelle DM (2018) Incidence and treatment of severe primary mitral regurgitation in contemporary clinical practice. Cardiovasc Revasc Med 19(8):960–963PubMedCrossRef
9.
Rosenhek R (2011) Watchful waiting for severe mitral regurgitation. Semin Thorac Cardiovasc Surg 23(3):203–208PubMedCrossRef
10.
Gillam LD, Schwartz A (2010) Is early surgery recommended for mitral regurgitation? Early surgery is recommended for mitral regurgitation response. Circulation 121(6):812
11.
Tietge WJ, de Heer LM, van Hessen MW, Jansen R, Bots ML, van Gilst W et al (2012) Early mitral valve repair versus watchful waiting in patients with severe asymptomatic organic mitral regurgitation; rationale and design of the Dutch AMR trial, a multicenter, randomised trial. Neth Heart J 20(3):94–101PubMedPubMedCentralCrossRef
12.
Penicka M, Vecera J, Mirica DC, Kotrc M, Kockova R, Van Camp G (2018) Prognostic implications of magnetic resonance-derived quantification in asymptomatic patients with organic mitral regurgitation: comparison with doppler echocardiography-derived integrative approach. Circulation 137(13):1349–1360PubMedCrossRef
13.
Chambers JB, Garbi M, Nieman K, Myerson S, Pierard LA, Habib G et al (2017) Appropriateness criteria for the use of cardiovascular imaging in heart valve disease in adults: a European Association of Cardiovascular Imaging report of literature review and current practice. Eur Heart J Cardiovasc Imaging 18(5):489–498PubMedCrossRef
14.
15.
Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V et al (2005) Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352(9):875–883PubMedCrossRef
16.
Hagendorff A, Knebel F, Helfen A, Stobe S, Haghi D, Ruf T et al (2021) Echocardiographic assessment of mitral regurgitation: discussion of practical and methodologic aspects of severity quantification to improve diagnostic conclusiveness. Clin Res Cardiol 110(11):1704–1733PubMedPubMedCentralCrossRef
17.
Uretsky S, Argulian E, Narula J, Wolff SD (2018) Use of cardiac magnetic resonance imaging in assessing mitral regurgitation: current evidence. J Am Coll Cardiol 71(5):547–563PubMedCrossRef
18.
Uretsky S, Supariwala A, Nidadovolu P, Khokhar SS, Comeau C, Shubayev O et al (2010) Quantification of left ventricular remodeling in response to isolated aortic or mitral regurgitation. J Cardiovasc Magn Reson 12(1):32PubMedPubMedCentralCrossRef
19.
Uretsky S, Gillam L, Lang R, Chaudhry FA, Argulian E, Supariwala A et al (2015) Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity a prospective multicenter trial. J Am Coll Cardiol 65(11):1078–1088PubMedCrossRef
20.
Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, Pennell DJ (2002) Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90(1):29–34PubMedCrossRef
21.
Harris AW, Krieger EV, Kim M, Cawley PJ, Owens DS, Hamilton-Craig C et al (2017) Cardiac magnetic resonance imaging versus transthoracic echocardiography for prediction of outcomes in chronic aortic or mitral regurgitation. Am J Cardiol 119(7):1074–1081PubMedCrossRef
22.
Garg P, Swift AJ, Zhong L, Carlhall CJ, Ebbers T, Westenberg J et al (2020) Assessment of mitral valve regurgitation by cardiovascular magnetic resonance imaging. Nat Rev Cardiol 17(5):298–312PubMedCrossRef
23.
Skoldborg V, Madsen PL, Dalsgaard M, Abdulla J (2020) Quantification of mitral valve regurgitation by 2D and 3D echocardiography compared with cardiac magnetic resonance a systematic review and meta-analysis. Int J Cardiovasc Imaging 36(2):279–289PubMedCrossRef
24.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol (Engl Ed) 74(9):790–799PubMedCrossRef
25.
Lancellotti P, Pibarot P, Chambers J, La Canna G, Pepi M, Dulgheru R et al (2022) Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper. Eur Heart J Cardiovasc Imaging 23(5):e171–e232PubMedCrossRef
26.
Myerson SG, d’Arcy J, Christiansen JP, Dobson LE, Mohiaddin R, Francis JM et al (2016) Determination of clinical outcome in mitral regurgitation with cardiovascular magnetic resonance quantification. Circulation 133(23):2287–2296PubMedCrossRef
27.
Kon MW, Myerson SG, Moat NE, Pennell DJ (2004) Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques. J Heart Valve Dis 13(4):600–607PubMed
28.
29.
Brugger N, Wustmann K, Hurzeler M, Wahl A, de Marchi SF, Steck H et al (2015) Comparison of three-dimensional proximal isovelocity surface area to cardiac magnetic resonance imaging for quantifying mitral regurgitation. Am J Cardiol 115(8):1130–1136PubMedCrossRef
30.
Capron T, Cautela J, Scemama U, Miola C, Bartoli A, Theron A et al (2020) Cardiac magnetic resonance assessment of left ventricular dilatation in chronic severe left-sided regurgitations: comparison with standard echocardiography. Diagn Interv Imaging 101(10):657–665PubMedCrossRef
31.
Cawley PJ, Hamilton-Craig C, Owens DS, Krieger EV, Strugnell WE, Mitsumori L et al (2013) Prospective comparison of valve regurgitation quantitation by cardiac magnetic resonance imaging and transthoracic echocardiography. Circ Cardiovasc Imaging 6(1):48–57PubMedCrossRef
32.
Choi J, Heo R, Hong GR, Chang HJ, Sung JM, Shin SH et al (2014) Differential effect of 3-dimensional color Doppler echocardiography for the quantification of mitral regurgitation according to the severity and characteristics. Circ Cardiovasc Imaging 7(3):535–544PubMedCrossRef
33.
ElTahlawy WM, Ragab TM, Elkhashab KA, Ebeid HM (2021) Quantification of mitral regurgitation using transthoracic echocardiography and cardiac magnetic resonance imaging. Rev Cardiovasc Med 22(1):215–223PubMedCrossRef
34.
Guo YK, Yang ZG, Ning G, Rao L, Dong L, Pen Y et al (2009) Sixty-four-slice multidetector computed tomography for preoperative evaluation of left ventricular function and mass in patients with mitral regurgitation: comparison with magnetic resonance imaging and echocardiography. Eur Radiol 19(9):2107–2116PubMedCrossRef
35.
Hamada S, Altiok E, Frick M, Almalla M, Becker M, Marx N, Hoffmann R (2012) Comparison of accuracy of mitral valve regurgitation volume determined by three-dimensional transesophageal echocardiography versus cardiac magnetic resonance imaging. Am J Cardiol 110(7):1015–1020PubMedCrossRef
36.
Hassan AKM, Algowhary MI, Kishk AYT, Youssef AAA, Razik NA (2020) Cardiac magnetic resonance assessment of mitral regurgitation severity appears better than echocardiographic imaging. Int J Cardiovas Imag 36(5):889–897CrossRef
37.
Heo R, Son JW, Hartaigh BO, Chang HJ, Kim YJ, Datta S et al (2017) Clinical implications of three-dimensional real-time color doppler transthoracic echocardiography in quantifying mitral regurgitation: a comparison with conventional two-dimensional methods. J Am Soc Echocardiogr 30(4):393-403.e7PubMedCrossRef
38.
Jang JY, Kang JW, Yang DH, Lee S, Sun BJ, Kim DH et al (2018) Impact of a geometric correction for proximal flow constraint on the assessment of mitral regurgitation severity using the proximal flow convergence method. J Cardiovasc Ultrasound 26(1):33–39PubMedPubMedCentralCrossRef
39.
Le Goffic C, Toledano M, Ennezat PV, Binda C, Castel AL, Delelis F et al (2015) Quantitative evaluation of mitral regurgitation secondary to mitral valve prolapse by magnetic resonance imaging and echocardiography. Am J Cardiol 116(9):1405–1410PubMedCrossRef
40.
Levy F, Marechaux S, Iacuzio L, Schouver ED, Castel AL, Toledano M et al (2018) Quantitative assessment of primary mitral regurgitation using left ventricular volumes obtained with new automated three-dimensional transthoracic echocardiographic software: a comparison with 3-Tesla cardiac magnetic resonance. Arch Cardiovasc Dis 111(8–9):507–517PubMedCrossRef
41.
Levy F, Iacuzio L, Marechaux S, Civaia F, Dommerc C, Wautot F et al (2021) Influence of prolapse volume in mitral valve prolapse. Am J Cardiol 157:64–70PubMedCrossRef
42.
Lopez-Mattei JC, Ibrahim H, Shaikh KA, Little SH, Shah DJ, Maragiannis D, Zoghbi WA (2016) Comparative assessment of mitral regurgitation severity by transthoracic echocardiography and cardiac magnetic resonance using an integrative and quantitative approach. Am J Cardiol 117(2):264–270PubMedCrossRef
43.
Militaru S, Bonnefous O, Hami K, Langet H, Houard L, Allaire S et al (2020) Validation of semiautomated quantification of mitral valve regurgitation by three-dimensional color doppler transesophageal echocardiography. J Am Soc Echocardiogr 33(3):342–354PubMedCrossRef
44.
Shanks M, Siebelink HMJ, Delgado V, van de Veire NRL, Ng ACT, Sieders A et al (2010) Quantitative assessment of mitral regurgitation comparison between three-dimensional transesophageal echocardiography and magnetic resonance imaging. Circ Cardiovasc Imag 3(6):694–700CrossRef
45.
Son JW, Chang HJ, Lee JK, Chung HJ, Song RY, Kim YJ et al (2013) Automated quantification of mitral regurgitation by three dimensional real time full volume color Doppler transthoracic echocardiography: a validation with cardiac magnetic resonance imaging and comparison with two dimensional quantitative methods. J Cardiovasc Ultrasound 21(2):81–89PubMedPubMedCentralCrossRef
46.
Spampinato RA, Lindemann F, Jahnke C, Paetsch I, Fahr F, Sieg F et al (2021) Quantification of regurgitation in mitral valve prolapse with automated real time echocardiographic 3D proximal isovelocity surface area: multimodality consistency and role of eccentricity index. Int J Cardiovasc Imaging 37(6):1947–1959PubMedPubMedCentralCrossRef
47.
Uretsky S, Argulian E, Supariwala A, Marcoff L, Koulogiannis K, Aldaia L et al (2018) A comparative assessment of echocardiographic parameters for determining primary mitral regurgitation severity using magnetic resonance imaging as a reference standard. J Am Soc Echocardiog 31(9):992–999CrossRef
48.
Uretsky S, Animashaun IB, Sakul S, Aldaia L, Marcoff L, Koulogiannis K et al (2022) American Society of Echocardiography Algorithm for degenerative mitral regurgitation: comparison with CMR. JACC Cardiovasc Imaging 15(5):747–760PubMedCrossRef
49.
Van De Heyning CM, Magne J, Pierard LA, Bruyere PJ, Davin L, De Maeyer C et al (2013) Assessment of left ventricular volumes and primary mitral regurgitation severity by 2D echocardiography and cardiovascular magnetic resonance. Cardiovasc Ultrasound 11:46PubMedCrossRef
50.
51.
Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S (2005) Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 7(5):775–782PubMedCrossRef
52.
Nayak KS, Nielsen JF, Bernstein MA, Markl M, Gatehouse PD, Botnar RM et al (2015) Cardiovascular magnetic resonance phase contrast imaging. J Cardiovasc Magn Reson 17(1):71PubMedPubMedCentralCrossRef
53.
Mathew RC, Loffler AI, Salerno M (2018) Role of Cardiac Magnetic Resonance Imaging in Valvular Heart Disease: Diagnosis, Assessment, and Management. Curr Cardiol Rep 20(11):119PubMedPubMedCentralCrossRef
54.
Cawley PJ, Maki JH, Otto CM (2009) Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation 119(3):468–478PubMedCrossRef
55.
Marwick TH, Neubauer S, Petersen SE (2013) Use of cardiac magnetic resonance and echocardiography in population-based studies: why, where, and when? Circ Cardiovasc Imaging 6(4):590–596PubMedCrossRef
56.
American College of Cardiology Foundation Task Force on Expert Consensus D, Hundley WG, Bluemke DA, Finn JP, Flamm SD, Fogel MA et al (2010) ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 55(23):2614–2662CrossRef
57.
Alfakih K, Reid S, Jones T, Sivananthan M (2004) Assessment of ventricular function and mass by cardiac magnetic resonance imaging. Eur Radiol 14(10):1813–1822PubMedCrossRef
58.
Dominici C, Salsano A, Nenna A, Spadaccio C, Barbato R, Mariscalco G et al (2020) Higher preoperative left atrial volume index predicts lack of mitral regurgitation improvement after transcatheter aortic valve replacement. J Cardiovasc Med (Hagerstown) 21(5):383–390PubMedCrossRef
59.
Essayagh B, Antoine C, Benfari G, Messika-Zeitoun D, Michelena H, Le Tourneau T et al (2019) Prognostic implications of left atrial enlargement in degenerative mitral regurgitation. J Am Coll Cardiol 74(7):858–870PubMedCrossRef
60.
Kronzon I, Tunick PA, Freedberg RS, Trehan N, Rosenzweig BP, Schwinger ME (1991) Transesophageal echocardiography is superior to transthoracic echocardiography in the diagnosis of sinus venosus atrial septal-defect. J Am Coll Cardiol 17(2):537–542PubMedCrossRef
61.
de Bruijn SFTM, Agema WRP, Lammers GJ, van der Wall EE, Wolterbeek R, Holman ER et al (2006) Transesophageal echocardiography is superior to transthoracic echocardiography in management of patients of any age with transient ischemic attack or stroke. Stroke 37(10):2531–2534PubMedCrossRef
Metadata
Title
Disparities in quantification of mitral valve regurgitation between cardiovascular magnetic resonance imaging and trans-thoracic echocardiography: a systematic review
Authors
Sulayman el Mathari
Rahul A. Bhoera
Luuk H. G. A. Hopman
Josephine Heidendael
Arjan Malekzadeh
Aart Nederveen
Pim van Ooij
Marco J. W. Götte
Jolanda Kluin
Publication date
05-11-2024
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-024-03280-y

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Keynote webinar | Spotlight on medication adherence

  • Webinar | 27-06-2024 | 18:00 (CEST)

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Watch now
Image Credits